Overview

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy

Status:
Withdrawn

Trial end date:
2008-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy, safety and tolerability of palifermin on the incidence of oral mucositis in subjects with locally advanced head and neck cancer receiving postoperative radiotherapy.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Swedish Orphan Biovitrum

Collaborator:

Amgen